Two-Year Clinical Outcome after Carvedilol-Loaded Stent Implantation in Patients with Coronary Artery Disease |
Kim, Hyun-Kuk
(Department of Internal Medicine, The Heart Center of Chonnam National University Hospital)
Hong, Young-Joon (Department of Internal Medicine, The Heart Center of Chonnam National University Hospital) Jeong, Myung-Ho (Department of Internal Medicine, The Heart Center of Chonnam National University Hospital) Kim, Weon (Cardiovascular Division, Department of Internal Medicine, Kyung Hee University Medical Hospital) Kim, Sung-Soo (Department of Internal Medicine, The Heart Center of Chonnam National University Hospital) Ko, Jum-Suk (Department of Internal Medicine, The Heart Center of Chonnam National University Hospital) Lee, Min-Goo (Department of Internal Medicine, The Heart Center of Chonnam National University Hospital) Sim, Doo-Sun (Department of Internal Medicine, The Heart Center of Chonnam National University Hospital) Park, Keun-Ho (Department of Internal Medicine, The Heart Center of Chonnam National University Hospital) Yoon, Nam-Sik (Department of Internal Medicine, The Heart Center of Chonnam National University Hospital) Yoon, Hyun-Ju (Department of Internal Medicine, The Heart Center of Chonnam National University Hospital) Kim, Kye-Hun (Department of Internal Medicine, The Heart Center of Chonnam National University Hospital) Park, Hyung-Wook (Department of Internal Medicine, The Heart Center of Chonnam National University Hospital) Kim, Ju-Han (Department of Internal Medicine, The Heart Center of Chonnam National University Hospital) Ahn, Young-Keun (Department of Internal Medicine, The Heart Center of Chonnam National University Hospital) Cho, Jeong-Gwan (Department of Internal Medicine, The Heart Center of Chonnam National University Hospital) Park, Jong-Chun (Department of Internal Medicine, The Heart Center of Chonnam National University Hospital) Kang, Jung-Chaee (Department of Internal Medicine, The Heart Center of Chonnam National University Hospital) |
1 | Grewe PH, Deneke T, Machraoui A, Barmeyer J, Muller KM. Acute and chronic tissue response to coronary stent implantation: pathologic findings in human specimen. J Am Coll Cardiol 2000;35:157-163. DOI ScienceOn |
2 | Farb A, Sangiorgi G, Carter AJ, et al. Pathology of acute and chronic coronary stenting in humans. Circulation 1999;99:44-52. DOI ScienceOn |
3 | Kornowski R, Hong MK, Tio FO, Bramwell O, Wu H, Leon MB. In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol 1998;31:224-230. DOI |
4 | Yue TL, Cheng HY, Lysko PG, et al. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger. J Pharmacol Exp Ther 1992;263:92-98. |
5 | Ohlstein EH, Douglas SA, Sung CP, et al. Carvedilol, a cardiovascular drug, prevents vascular smooth muscle cell proliferation, migration, and neointimal formation following vascular injury. Proc Natl Acad Sci U S A 1993;90:6189-6193. DOI ScienceOn |
6 | Sung CP, Arleth AJ, Ohlstein EH. Carvedilol inhibits vascular smooth muscle cell proliferation. J Cardiovasc Pharmacol 1993;21:221-227. DOI ScienceOn |
7 | Park J, Ha H, Kim MS, Ahn HJ, Huh KH, Kim YS. Carvedilol inhibits platelet-derived growth factor-induced extracellular matrix synthesis by inhibiting cellular reactive oxygen species and mitogen-activated protein kinase activation. J Heart Lung Transplant 2006;25:683-689. DOI ScienceOn |
8 | Kim W, Jeong MH, Cha KS, et al. Effect of anti-oxidant (carvedilol and probucol) loaded stents in a porcine coronary restenosis model. Circ J 2005;69:101-106. DOI ScienceOn |
9 | Cutlip DE, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007;115:2344-2351. DOI ScienceOn |
10 | Park SJ, Shim WH, Ho DS, et al. A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med 2003;348:1537-1545. DOI ScienceOn |
11 | Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-1323. DOI ScienceOn |
12 | Spaulding C, Daemen J, Boersma E, Cutlip DE, Serruys PW. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2007;356:989-997. DOI ScienceOn |
13 | Bavry AA, Kumbhani DJ, Helton TJ, Borek PP, Mood GR, Bhatt DL. Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials. Am J Med 2006;119:1056-1061. DOI ScienceOn |
14 | Inoue T, Node K. Molecular basis of restenosis and novel issues of drug-eluting stents. Circ J 2009;73:615-621. DOI ScienceOn |
15 | Luscher TF, Steffel J, Eberli FR, et al. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation 2007;115:1051-1058. DOI ScienceOn |
16 | Feuerstein GZ, Ruffolo RR Jr. Carvedilol, a novel vasodilating beta-blocker with the potential for cardiovascular organ protection. Eur Heart J 1996;17 Suppl B:24-29. DOI ScienceOn |
17 | Tanous D, Brasen JH, Choy K, et al. Probucol inhibits in-stent thrombosis and neointimal hyperplasia by promoting re-endothelialization. Atherosclerosis 2006;189:342-349. DOI ScienceOn |